| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| 无 |
Peking University Third Hospital |
|
|
|
2026-07-13 | 15 | Patient list |
| NCT 07410039 |
Eculizumab Add-On Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study The First Medical Center of Chinese People's Liberation Army General Hospital |
Neuromyelitis Optica Spectrum Disorders |
|
|
2026-06-26 | 201 | Patient list |
| 无 |
Efficacy Exploration and Safety Evaluation of an Emulsion Beijing Yiweishi Testing Technology Co., Ltd. |
|
Therapy Study |
Premarket |
2026-06-22 | 188 | Patient list |
| 284791 |
Peking University Cancer Hospital & Institute |
Cancer |
Diagnostic Accuracy Test |
|
2026-05-13 | 369 | Patient list |
| ChiCTR2400081518 |
Beijing Hospital |
infectious diseases |
Therapy Study |
Premarket |
2026-01-19 | 834 | Patient list |
| ChiCTR2400081762 |
PLA Rocket Force Characteristic Medical Center |
Gastroesophageal reflux disease |
Therapy Study |
|
2026-01-14 | 623 | Patient list |
| ChiCTR2500104855 |
Fuwai Hospital, Chinese Academy of Medical Sciences |
|
Diagnostic Accuracy Test |
Post-market |
2025-11-28 | 419 | Patient list |
| pgyy2025-07 |
Beijing Pinggu District Hospital |
|
|
|
2025-11-22 | 491 | Patient list |
| - |
Beijing Chest Hospital, Capital Medical University |
Tuberculosis |
Therapy Study |
Post-market |
2025-10-30 | 531 | Patient list |
| ChiCTR2500096010 |
Beijing Hospital |
|
Diagnostic Accuracy Test |
Post-market |
2025-09-30 | 903 | Patient list |




